Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Low-Dose Dasatinib As First-Line Treatment for Chronic Myeloid Leukemia: Preliminary Report

Paola Santana-Hernandez, Perla Rocio Colunga Pedraza, MD, Guillermo Sotomayor Duque, MD, Andrés Gómez-De León, MD, Luz del Carmen Tarín Arzaga, MD, Cesar Homero Gutierrez Aguirre, Olga Cantu Rodriguez, MD, David Gomez-Almaguer, MD

Blood (2017) 130 (Supplement 1): 5254.

https://doi.org/10.1182/blood.V130.Suppl_1.5254.5254

Published: 2017

Journal Articles

Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Feasible. Experience in a Single Latin-American Center

Perla Rocio Colunga Pedraza, MD, Andres Gomez De Leon, MD, Guillermo Sotomayor Duque, MD, Julia Esther Colunga Pedraza, MD, Yadith Karina López García, Paola Santana-Hernandez, Cesar Homero Gutierrez Aguirre, Olga Cantu Rodriguez, MD, Luz del Carmen Tarín Arzaga, MD, Oscar Gonzalez Llano, MD, David Gomez-Almaguer, MD

Blood (2017) 130 (Supplement 1): 1940.

https://doi.org/10.1182/blood.V130.Suppl_1.1940.1940

Published: 2017

Journal Articles

Low-Dose Plerixafor and Granulocyte Colony-Stimulating Factor for First-Line Autologous Peripheral Blood Stem Cell Mobilization in Lymphoma and Multiple Myeloma

Cesar Homero Gutierrez Aguirre, David Gomez-Almaguer, MD, Dalila Marisol Alvarado Navarro, MD, Rosario Salazar Riojas, Olga Cantu Rodriguez, MD, Luz del Carmen Tarín Arzaga, MD, Gerardo Mejia Jaramillo, Guillermo Sotomayor Duque, MD, Andres Gomez De Leon, MD, Perla Rocio Colunga Pedraza, MD

Blood (2017) 130 (Supplement 1): 5459.

https://doi.org/10.1182/blood.V130.Suppl_1.5459.5459

Published: 2017

Journal Articles

Eltrombopag, Low-Dose Rituximab, and High-Dose Dexamethasone Combination for Patients with Newly Diagnosed Immune Thrombocytopenia: A Pilot "Total Therapy" Study

David Gomez-Almaguer, MD, Olga Cantu-Rodriguez, MD, Cesar Homero Gutierrez-Aguirre, MD, Jose Carlos Jaime-Perez, MD PhD, Luz C. Tarin-Arzaga, MD, Monica Sanchez Cardenas, MD, Rosa Elena Lozano-Morales, MD, Guillermo Sotomayor Duque, MD, Daniela Cárdenas-Araujo, MD, Andres Gomez-de Leon, MD, Paola Santana-Hernandez, Perla Rocío Colunga-Pedraza, MD

Blood (2016) 128 (22): 1369.

https://doi.org/10.1182/blood.V128.22.1369.1369

Published: 2016

Journal Articles

Danazol As First-Line Therapy for Myelodysplastic Syndromes

Perla Rocío Colunga-Pedraza, MD, Alejandra Garza-Ledezma, MD, Julia Colunga-Pedraza, Olga Cantu-Rodriguez, MD, Rosa Elena Lozano-Morales, MD, Guillermo Sotomayor Duque, MD, Erika Cazares-Rendón, Erick J Rendón-Ramírez, MD, Cesar Homero Gutierrez-Aguirre, MD, Luz Tarin-Arzaga, MD, David Gomez-Almaguer, MD

Blood (2016) 128 (22): 5528.

https://doi.org/10.1182/blood.V128.22.5528.5528

Published: 2016

NARROW

Low-Dose Dasatinib As First-Line Treatment for Chronic Myeloid Leukemia: Preliminary Report

Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Feasible. Experience in a Single Latin-American Center

Low-Dose Plerixafor and Granulocyte Colony-Stimulating Factor for First-Line Autologous Peripheral Blood Stem Cell Mobilization in Lymphoma and Multiple Myeloma

Eltrombopag, Low-Dose Rituximab, and High-Dose Dexamethasone Combination for Patients with Newly Diagnosed Immune Thrombocytopenia: A Pilot "Total Therapy" Study

Danazol As First-Line Therapy for Myelodysplastic Syndromes

Email alerts

ASH Publications

American Society of Hematology

Low-Dose Dasatinib As First-Line Treatment for Chronic Myeloid Leukemia: Preliminary Report

Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Feasible. Experience in a Single Latin-American Center

Low-Dose Plerixafor and Granulocyte Colony-Stimulating Factor for First-Line Autologous Peripheral Blood Stem Cell Mobilization in Lymphoma and Multiple Myeloma

Eltrombopag, Low-Dose Rituximab, and High-Dose Dexamethasone Combination for Patients with Newly Diagnosed Immune Thrombocytopenia: A Pilot "Total Therapy" Study

Danazol As First-Line Therapy for Myelodysplastic Syndromes

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only